Eleven people were killed in the strike, the Lebanese Health Ministry stated.
The IDF struck terrorists operating in a Hamas training compound in the Ain al-Hilweh area in southern Lebanon, the military said Tuesday.
The IDF said it is working against the establishment of the Hamas terrorist organization in Lebanon, and will continue to “act forcefully against Hamas terrorists wherever they operate.”
The IDF strikes terrorists operating in a Hamas training compound in the Ain al-Hilweh area in southern Lebanon, November 18, 2025. (credit: Section 27A of the Copyright Act)
Eleven people were killed in the strike, the Lebanese Health Ministry stated.
The training facility that was attacked had been under surveillance for a long time, IDF sources told Ynet.
Intelligence teams were waiting for an opportunity when dozens of junior terrorists would gather in order to strike, the source said.
Reuters contributed to this report.
This is a developing story.
LATEST POSTS
- 1
The most effective method to Move toward Compensation Conversations for Cutting edge Practice Enrolled Attendants - 2A coup too far: Why Benin's rebel soldiers failed where others in the region succeeded
- 3Kelsey Grammer on having a new baby at 70: 'You're just more available now'
- 42024 Moving Styles for Kitchen Redesigns
- 5Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
- 2024's Driving Clearing Robots: Master Suggestions and Surveys
- Presenting Nintendo's New Pastel Bliss Con Tones for Switch Gamers: 3 Smart Choices
- ‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- Untamed life Safe-havens All over the Planet Offering Remarkable Creature Experiences
- Vote in favor of your Number one method for praising a birthday
- Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
- Dirty soda started as a Mormon alternative to booze. Now it's everywhere.
- Four Dead in Last Month From Animal Attacks in Nepal
- Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
